特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
971214

パイロジェンテストの世界市場 (~2025年): 製品&サービス (アッセイ/キット/試薬・機器・サービス)・テストタイプ (LAL・発色・比濁・ゲル化・インビトロ・ラビット)・エンドユーザー (製薬・バイオテクノロジー・医療機器)・地域別

Pyrogen Testing Market by Product & Service(Assays, Kits, Reagents, Instruments, Services), Test Type(LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User(Pharmaceutical, Biotechnology, Medical Device), Region - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 166 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
パイロジェンテストの世界市場 (~2025年): 製品&サービス (アッセイ/キット/試薬・機器・サービス)・テストタイプ (LAL・発色・比濁・ゲル化・インビトロ・ラビット)・エンドユーザー (製薬・バイオテクノロジー・医療機器)・地域別
出版日: 2020年11月10日
発行: MarketsandMarkets
ページ情報: 英文 166 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のパイロジェンテストの市場規模は予測期間中12.7%のCAGRで推移し、2020年の9億2700万米ドルから、2025年には16億8900万米ドルに達し、予測期間中のCAGRは12.7%になると予測されています。感染症の発生率の上昇、パンデミックの頻度の増加、製薬およびバイオテクノロジー産業におけるR&Dの拡大、個別化医療への注目の高まり、慢性疾患の有病率の上昇などの要因が同市場の成長を推進しています。一方で、高度な市場統合が今後数年の市場成長をある程度抑制すると予測されています。

テストタイプ別では、LALテストの部門が高い成長率を示しています。革新的な臨床検査へのニーズの高まり、健康基準の向上、薬剤パイプラインの拡大、ワクチン開発への支援の増加などの要因が同部門の成長を推進しています。また、エンドユーザー別では、製薬およびバイオテクノロジー企業の部門が最大のCAGRを示しています。さらに、地域別では、アジア太平洋地域が予測期間中最大のCAGRを示す見通しです。中国および日本における成長、主要企業による新興アジア諸国への拡張、インドや中国などへの医薬品アウトソーシングの増加傾向などの要因が同地域の成長を後押ししています。

当レポートでは、世界のパイロジェンテストの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、製品&サービス・テストタイプ・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 動向
  • COVID-19の影響
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析

第6章 市場分析・予測:製品・サービス別

  • アッセイ・キット・試薬
  • 機器
  • サービス

第7章 市場分析・予測:テストタイプ別

  • LALテスト
    • 発色試験
    • 比濁試験
    • ゲル化試験
  • インビトロ試験
  • ラビット試験

第8章 市場分析・予測:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 医療機器企業
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 企業評価クアドラント
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • CHARLES RIVER LABORATORIES, INC.
    • LONZA
    • MERCK KGAA
    • THERMO FISHER SCIENTIFIC, INC.
    • ASSOCIATES OF CAPE COD, INC.
    • BIOMERIEUX SA
    • GENSCRIPT BIOTECH CORPORATION
    • EUROFINS SCIENTIFIC
    • WUXI APPTEC
    • STERIS PLC
  • その他の企業
    • ELLAB A/S
    • FUJIFILM WAKO PURE CHEMICAL CORPORATION
    • INVIVOGEN
    • NELSON LABORATORIES, LLC
    • MICROCOAT BIOTECHNOLOGIE GMBH
    • HYCULT BIOTECH
    • ALMAC GROUP
    • PACIFIC BIOLABS
    • ACCUGEN LABORATORIES, INC.
    • TOXIKON
    • MINERVA ANALYTIX GMBH
    • INDOOR BIOTECHNOLOGIES, INC.
    • CREATIVE BIOARRAY
    • LUCIDEON LIMITED
    • NORTH AMERICAN SCIENCE ASSOCIATES, INC.

第12章 付録

目次
Product Code: BT 3175

The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, and the rising prevalence of chronic diseases. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.

"The assays, kits, & reagents accounted for the highest growth rate in the pyrogen testing market, by product & service, during the forecast period"

The pyrogen testing market is segmented into assays, kits, & reagents, instruments, and services based on product & service. The assays, kits, & reagents segment accounted for the highest growth rate in the pyrogen testing market in 2019. The requirement of assays, kits, & reagents in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays, kits, & reagents compared to instruments and the rising preference for kit-based testing.

"LAL tests segment accounted for the highest CAGR"

Based on the test type, the pyrogen testing market is segmented into LAL tests, in vitro tests, and rabbit tests. The LAL tests segment is further categorized into chromogenic tests, turbidimetric tests, and gel clot tests. In 2019, the LAL tests segment accounted for the highest growth rate. The rising need for innovative laboratory testing procedures, increasing health standards, growing drug pipelines, and the increasing support for vaccine development are the major factors driving this segment's growth.

"Pharmaceutical & biotechnology companies segment accounted for the highest CAGR"

Based on end-users, the pyrogen testing market is segmented into pharmaceutical & biotechnology companies, medical device companies, and other end users. In 2019, the pharmaceutical & biotechnology companies segment accounted for the highest growth rate. This can be attributed to many ongoing drug discovery activities and the increasing number of R&D facilities globally.

"Asia Pacific: The fastest-growing region pyrogen testing market"

The global pyrogen testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the pyrogen testing market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6% , and the Middle East & Africa - 4%

Lits of Companies Profiled in the Report:

  • Charles River Laboratories, Inc. (US)
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Associates of Cape Cod, Inc. (US)
  • GenScript Biotech Corporation (China)
  • bioMerieux SA (France)
  • FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Eurofins Scientific (Luxembourg)
  • WuXi AppTec (China)
  • Hycult Biotech (Netherlands)
  • Ellab A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • InvivoGen (US)
  • Nelson Laboratories, LLC (US)
  • Almac Group (UK)
  • Pacific Biolabs (US)
  • STERIS plc (US)
  • Accugen Laboratories, Inc. (US)
  • TOXIKON (US)
  • Minerva Analytix GmbH (Germany)
  • Indoor Biotechnologies, Inc. (US)
  • Creative Bioarray (US)
  • Lucideon Limited (UK)
  • North American Science Associates, Inc. (US)

Research Coverage:

This report provides a detailed picture of the global pyrogen testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pyrogen testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 PYROGEN TESTING MARKET
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 PYROGEN TESTING MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 PYROGEN TESTING MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 5 PYROGEN TESTING MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 PYROGEN TESTING MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 PYROGEN TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 PYROGEN TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 PYROGEN TESTING MARKET OVERVIEW
    • FIGURE 11 INCREASING R&D IN THE PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES IS DRIVING THE GROWTH OF THE PYROGEN TESTING MARKET
  • 4.2 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 ASSAYS, KITS, & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
  • 4.3 PYROGEN TESTING MARKET SHARE, BY END USER, 2020 VS. 2025
    • FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS & SERVICES
  • 4.4 PYROGEN TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE PYROGEN TESTING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 PYROGEN TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of infectious diseases and increasing frequency of pandemics
      • 5.2.1.2 Increasing R&D in the pharmaceutical & biotechnology industries
    • FIGURE 16 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017-2024
      • 5.2.1.3 Growing focus on personalized medicine
    • TABLE 1 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
      • 5.2.1.4 Growing awareness about food safety
    • FIGURE 17 NUMBER OF FOODBORNE DISEASE OUTBREAKS REPORTED TO ORU/NICD, SOUTH AFRICA, 2013-2017
      • 5.2.1.5 High prevalence of chronic diseases
    • FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045 (MILLION CASES)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High degree of consolidation
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing pharmaceutical outsourcing
      • 5.2.3.2 Emerging markets offer lucrative opportunities
    • 5.2.4 TRENDS
      • 5.2.4.1 Shift from animal-based testing to in vitro testing
  • 5.3 IMPACT OF COVID-19 ON THE PYROGEN TESTING MARKET
  • 5.4 PRICING ANALYSIS
    • TABLE 2 PRICE OF PYROGEN TESTING PRODUCTS (2020)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.7 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 22 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY

6 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 3 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 6.2 ASSAYS, KITS, & REAGENTS
    • 6.2.1 REPEAT PURCHASES OF ASSAYS, KITS, & REAGENTS TO DRIVE THE MARKET GROWTH
    • TABLE 4 PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 5 NORTH AMERICA: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 6 EUROPE: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 7 ASIA PACIFIC: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 CONTINUOUS INNOVATION IN TECHNOLOGICALLY ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
    • TABLE 8 PYROGEN TESTING INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 9 NORTH AMERICA: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 EUROPE: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 11 ASIA PACIFIC: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 LACK OF EXPERTISE AND INFRASTRUCTURE FOR ANALYTICAL & QUALITY TESTING DRIVES RELIANCE ON SERVICE PROVIDERS
    • TABLE 12 PYROGEN TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 13 NORTH AMERICA: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 14 EUROPE: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 15 ASIA PACIFIC: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 PYROGEN TESTING MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 16 PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
  • 7.2 LAL TESTS
    • TABLE 17 LAL TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 18 LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 7.2.1 CHROMOGENIC TESTS
      • 7.2.1.1 Ease of use & cost-effectiveness of chromogenic tests to support market growth
    • TABLE 19 KEY PRODUCTS IN THE CHROMOGENIC TESTS MARKET, BY COMPANY
    • TABLE 20 CHROMOGENIC TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 TURBIDIMETRIC TESTS
      • 7.2.2.1 Higher precision of kinetic turbidimetric tests have supported their adoption
    • TABLE 21 KEY PRODUCTS IN THE TURBIDIMETRIC TESTS MARKET, BY COMPANY
    • TABLE 22 TURBIDIMETRIC TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.3 GEL CLOT TESTS
      • 7.2.3.1 Endotoxin determination with gel clot test method is simpler and more economical
    • TABLE 23 KEY PRODUCTS IN THE GEL CLOT TESTS MARKET, BY COMPANY
    • TABLE 24 GEL CLOT TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 IN VITRO TESTS
    • 7.3.1 APPLICABILITY TO A GREATER VARIETY OF PRODUCTS IS DRIVING THE GROWTH OF THIS SEGMENT
    • TABLE 25 IN VITRO TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 RABBIT TESTS
    • 7.4.1 INCREASING FOCUS ON THE USE OF NON-ANIMAL-BASED TESTING METHODS TO LIMIT MARKET GROWTH
    • TABLE 26 RABBIT TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 PYROGEN TESTING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 27 PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS
    • TABLE 28 PYROGEN TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 MEDICAL DEVICE COMPANIES
    • 8.3.1 RISING NEED TO ENSURE THE SAFETY OF MANUFACTURED MEDICAL DEVICES HAS DRIVEN THE ADOPTION OF PYROGEN TESTING PRODUCTS
    • TABLE 29 PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 30 PYROGEN TESTING MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

9 PYROGEN TESTING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 31 PYROGEN TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: PYROGEN TESTING MARKET SNAPSHOT
    • TABLE 32 NORTH AMERICA: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 33 NORTH AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 34 NORTH AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 36 NORTH AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American market
    • TABLE 37 US: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 38 US: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 39 US: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 40 US: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Support from government organizations is driving the growth of the pyrogen testing market in Canada
    • TABLE 41 CANADA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 42 CANADA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 43 CANADA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 44 CANADA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 45 EUROPE: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 46 EUROPE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 47 EUROPE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 48 EUROPE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 49 EUROPE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany holds the largest share of the European market
    • TABLE 50 GERMANY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 51 GERMANY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 52 GERMANY: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 53 GERMANY: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Growth of the pharmaceutical & biotechnology industry to drive the market in the UK
    • TABLE 54 UK: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 55 UK: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 56 UK: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 UK: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
    • TABLE 58 FRANCE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 59 FRANCE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 FRANCE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 61 FRANCE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growth in this market is mainly driven by increasing life science R&D
    • TABLE 62 ITALY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 63 ITALY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 64 ITALY: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 ITALY: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing outsourcing of microbial testing services to fuel the adoption of pyrogen testing
    • TABLE 66 SPAIN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 67 SPAIN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 68 SPAIN: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 SPAIN: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 70 ROE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 71 ROE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 72 ROE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 73 ROE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: PYROGEN TESTING MARKET SNAPSHOT
    • TABLE 74 APAC: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 75 APAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 76 APAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 77 APAC: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 78 APAC: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China dominates the market in the APAC
    • TABLE 79 CHINA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 80 CHINA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 CHINA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 CHINA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Expansion of pharmaceutical manufacturing plants in Japan to create market growth opportunities
    • TABLE 83 JAPAN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 84 JAPAN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 JAPAN: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 86 JAPAN: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 India's growing contract research and manufacturing industry will favor the pyrogen testing market
    • TABLE 87 INDIA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 88 INDIA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 INDIA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 90 INDIA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 91 ROAPAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 92 ROAPAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 ROAPAC: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 ROAPAC: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 GROWING CONTRACT RESEARCH & MANUFACTURING ACTIVITIES TO SUPPORT THE MARKET GROWTH
    • TABLE 95 LATIN AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 96 LATIN AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 LATIN AMERICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 LATIN AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
    • TABLE 99 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 100 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 25 KEY DEVELOPMENTS IN THE PYROGEN TESTING MARKET
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 26 PYROGEN TESTING MARKET SHARE, BY KEY PLAYER (2019)
  • 10.3 COMPANY EVALUATION QUADRANT
    • 10.3.1 VENDOR EXCLUSION CRITERIA
    • 10.3.2 STARS
    • 10.3.3 EMERGING LEADERS
    • 10.3.4 PERVASIVE PLAYERS
    • 10.3.5 PARTICIPANTS
    • FIGURE 27 PYROGEN TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 10.4 COMPETITIVE SCENARIO
    • 10.4.1 PRODUCT LAUNCHES
    • TABLE 103 KEY PRODUCT LAUNCHES
    • 10.4.2 ACQUISITIONS
    • TABLE 104 KEY ACQUISITIONS
    • 10.4.3 EXPANSIONS
    • TABLE 105 KEY EXPANSIONS
    • 10.4.4 AGREEMENTS
    • TABLE 106 KEY AGREEMENTS
    • 10.4.5 PARTNERSHIPS
    • TABLE 107 KEY PARTNERSHIPS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.1.1 CHARLES RIVER LABORATORIES, INC.
    • FIGURE 28 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.2 LONZA
    • FIGURE 29 LONZA: COMPANY SNAPSHOT (2019)
    • 11.1.3 MERCK KGAA
    • FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 11.1.4 THERMO FISHER SCIENTIFIC, INC.
    • FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.5 ASSOCIATES OF CAPE COD, INC.
    • 11.1.6 BIOMERIEUX SA
    • FIGURE 32 BIOMERIEUX SA: COMPANY SNAPSHOT (2019)
    • 11.1.7 GENSCRIPT BIOTECH CORPORATION
    • FIGURE 33 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2019)
      • 11.1.7.2 Products offered
    • 11.1.8 EUROFINS SCIENTIFIC
    • FIGURE 34 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 11.1.9 WUXI APPTEC
    • FIGURE 35 WUXI APPTEC: COMPANY SNAPSHOT (2019)
    • 11.1.10 STERIS PLC
    • FIGURE 36 STERIS PLC: COMPANY SNAPSHOT (2019)
  • 11.2 OTHER PLAYERS
    • 11.2.1 ELLAB A/S
    • 11.2.2 FUJIFILM WAKO PURE CHEMICAL CORPORATION
    • 11.2.3 INVIVOGEN
    • 11.2.4 NELSON LABORATORIES, LLC
    • 11.2.5 MICROCOAT BIOTECHNOLOGIE GMBH
    • 11.2.6 HYCULT BIOTECH
    • 11.2.7 ALMAC GROUP
    • 11.2.8 PACIFIC BIOLABS
    • 11.2.9 ACCUGEN LABORATORIES, INC.
    • 11.2.10 TOXIKON
    • 11.2.11 MINERVA ANALYTIX GMBH
    • 11.2.12 INDOOR BIOTECHNOLOGIES, INC.
    • 11.2.13 CREATIVE BIOARRAY
    • 11.2.14 LUCIDEON LIMITED
    • 11.2.15 NORTH AMERICAN SCIENCE ASSOCIATES, INC.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.